Published in Diabet Med on February 01, 2007
Brain structure and obesity. Hum Brain Mapp (2010) 3.04
Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology (2011) 2.91
Thickness of the human cerebral cortex is associated with metrics of cerebrovascular health in a normative sample of community dwelling older adults. Neuroimage (2010) 1.23
Microstructural white matter abnormalities and cognitive functioning in type 2 diabetes: a diffusion tensor imaging study. Diabetes Care (2012) 1.22
Macro- and microstructural magnetic resonance imaging indices associated with diabetes among community-dwelling older adults. Diabetes Care (2012) 1.14
Influence of type 2 diabetes on brain volumes and changes in brain volumes: results from the Women's Health Initiative Magnetic Resonance Imaging studies. Diabetes Care (2012) 1.10
Association of type 2 diabetes with brain atrophy and cognitive impairment. Neurology (2014) 1.10
Type 2 diabetes as a risk factor for cognitive impairment: current insights. Clin Interv Aging (2014) 0.91
The influence of subclinical cardiovascular disease and related risk factors on cognition in type 2 diabetes mellitus: The DHS-Mind study. J Diabetes Complications (2013) 0.91
Diabetes as a chronic metabolic stressor: causes, consequences and clinical complications. Exp Neurol (2011) 0.90
Cross-sectional and longitudinal association of body mass index and brain volume. Hum Brain Mapp (2012) 0.87
Effect of diabetes on brain structure: the action to control cardiovascular risk in diabetes MR imaging baseline data. Radiology (2014) 0.86
Reduced blood flow in normal white matter predicts development of leukoaraiosis. J Cereb Blood Flow Metab (2015) 0.85
Lifetime hypertension as a predictor of brain structure in older adults: cohort study with a 28-year follow-up. Br J Psychiatry (2014) 0.83
Weight loss after bariatric surgery reverses insulin-induced increases in brain glucose metabolism of the morbidly obese. Diabetes (2013) 0.83
Diabetic peripheral microvascular complications: relationship to cognitive function. Cardiovasc Psychiatry Neurol (2011) 0.82
Type 2 diabetes mellitus, cognition and brain in aging: A brief review. Indian J Psychiatry (2009) 0.77
Differential associations between systemic markers of disease and cortical thickness in healthy middle-aged and older adults. Neuroimage (2016) 0.75
Relation of Dysglycemia to Structural Brain Changes in a Multiethnic Elderly Cohort. J Am Geriatr Soc (2016) 0.75
Framingham Coronary Heart Disease Risk Score Can be Predicted from Structural Brain Images in Elderly Subjects. Front Aging Neurosci (2014) 0.75
Relating education, brain structure, and cognition: the role of cardiovascular disease risk factors. Biomed Res Int (2014) 0.75
Role of the PI3K/AKT signalling pathway in apoptotic cell death in the cerebral cortex of streptozotocin-induced diabetic rats. Exp Ther Med (2017) 0.75
Genetic and physical maps of Saccharomyces cerevisiae. Nature (1997) 21.48
Consistent resting-state networks across healthy subjects. Proc Natl Acad Sci U S A (2006) 19.60
Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology (1993) 16.92
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med (2004) 16.58
A new generation of the IMAGIC image processing system. J Struct Biol (1996) 12.57
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
RPS2 of Arabidopsis thaliana: a leucine-rich repeat class of plant disease resistance genes. Science (1994) 8.99
MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol (1987) 8.48
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat Med (2000) 7.48
A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke (2001) 5.81
Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology (1993) 5.72
Reduced resting-state brain activity in the "default network" in normal aging. Cereb Cortex (2007) 5.28
Single-particle electron cryo-microscopy: towards atomic resolution. Q Rev Biophys (2000) 4.86
FCA, a gene controlling flowering time in Arabidopsis, encodes a protein containing RNA-binding domains. Cell (1997) 4.79
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet (2001) 4.55
The Arabidopsis downy mildew resistance gene RPP5 shares similarity to the toll and interleukin-1 receptors with N and L6. Plant Cell (1997) 4.53
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology (2006) 4.38
Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry (1992) 4.16
Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency. Neurology (2010) 3.98
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain (1997) 3.87
Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol (1999) 3.67
Specific C-receptors for itch in human skin. J Neurosci (1997) 3.51
Graph theoretical analysis of magnetoencephalographic functional connectivity in Alzheimer's disease. Brain (2008) 3.36
Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease. Neuroimage (2004) 3.25
A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci (1993) 3.16
Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment. Neurobiol Aging (2005) 3.00
Relation between age-related decline in intelligence and cerebral white-matter hyperintensities in healthy octogenarians: a longitudinal study. Lancet (2000) 2.97
Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology (1996) 2.94
Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment. J Neurol (1999) 2.92
A novel zinc finger protein is encoded by the Arabidopsis LSD1 gene and functions as a negative regulator of plant cell death. Cell (1997) 2.91
Postwithdrawal rebound increase in T2 lesional activity in natalizumab-treated MS patients. Neurology (2007) 2.88
Cortical lesions in multiple sclerosis. Brain (1999) 2.83
Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology (1998) 2.83
Incident lacunes influence cognitive decline: the LADIS study. Neurology (2011) 2.81
Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways. Blood (2000) 2.70
Construction of an intron-containing marker gene: splicing of the intron in transgenic plants and its use in monitoring early events in Agrobacterium-mediated plant transformation. Mol Gen Genet (1990) 2.69
A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry. Neuroimage (2003) 2.67
Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol (1999) 2.61
Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study. Stroke (2008) 2.57
Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl (2000) 2.56
Tumor initiators and promoters in the induction of Epstein-Barr virus. Proc Natl Acad Sci U S A (1979) 2.55
Forespore-specific transcription of a gene in the signal transduction pathway that governs Pro-sigma K processing in Bacillus subtilis. Genes Dev (1991) 2.53
Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl (2000) 2.52
Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol (2007) 2.47
Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology (2008) 2.41
Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment. J Neurol Neurosurg Psychiatry (2002) 2.41
Chemical response pattern of different classes of C-nociceptors to pruritogens and algogens. J Neurophysiol (2003) 2.39
Statins as immunomodulators: comparison with interferon-beta 1b in MS. Neurology (2002) 2.34
Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge. J Virol (2001) 2.30
Prevalence and severity of microbleeds in a memory clinic setting. Neurology (2006) 2.29
Indolent course of progressive multifocal leukoencephalopathy during natalizumab treatment in MS. Neurology (2011) 2.26
CIND and MCI in the Italian elderly: frequency, vascular risk factors, progression to dementia. Neurology (2007) 2.25
Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects. Neurology (2005) 2.24
A comparative linkage map of oilseed rape and its use for QTL analysis of seed oil and erucic acid content. Theor Appl Genet (2006) 2.21
EFNS guidelines for the diagnosis and management of Alzheimer's disease. Eur J Neurol (2010) 2.21
Small-vessel disease relates to poor poststroke survival in a 12-year follow-up. Neurology (2011) 2.19
Alexander disease: ventricular garlands and abnormalities of the medulla and spinal cord. Neurology (2006) 2.19
Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology (1998) 2.17
Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Neurology (2011) 2.17
Identification and map position of YAC clones comprising one-third of the Arabidopsis genome. Plant J (1991) 2.17
Postmortem verification of MS cortical lesion detection with 3D DIR. Neurology (2012) 2.16
Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis. Laryngoscope (1997) 2.15
Determinants of brain iron in multiple sclerosis: a quantitative 3T MRI study. Neurology (2011) 2.11
ClpS is an essential component of the N-end rule pathway in Escherichia coli. Nature (2006) 2.09
Determination of relative CMRO2 from CBF and BOLD changes: significant increase of oxygen consumption rate during visual stimulation. Magn Reson Med (1999) 2.06
Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. J Neurol Neurosurg Psychiatry (1991) 2.05
Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology (1988) 2.03
Regional DTI differences in multiple sclerosis patients. Neuroimage (2008) 2.03
White matter hyperintensities on MRI in the neurologically nondiseased elderly. Analysis of cohorts of consecutive subjects aged 55 to 85 years living at home. Stroke (1995) 2.01